We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Detects COVID-19 in Lung Ultrasound Images

By MedImaging International staff writers
Posted on 21 Mar 2024
Print article
Image: The automated detection tool could help ER doctors diagnose COVID-19 patients quickly and accurately (Photo courtesy of Adobe Stock)
Image: The automated detection tool could help ER doctors diagnose COVID-19 patients quickly and accurately (Photo courtesy of Adobe Stock)

During the onset of the pandemic, utilizing artificial intelligence (AI) to identify signs of COVID-19 in lung ultrasound images proved challenging due to limited patient data and a nascent understanding of the disease's manifestations. Though computational tools were applied to help detect COVID-19 from these images, the risk of misdiagnosis was high without adequately training and validating the AI to recognize features specific to COVID-19 in the lungs. Now, new research has led to the development of an AI tool that is capable of identifying COVID-19 in lung ultrasound images, similar to how facial recognition technology identifies faces in a crowd.

The AI tool developed by researchers at Johns Hopkins (Baltimore, MD, USA) is a deep neural network, a type of AI designed to mimic the interconnected neurons that enable the brain to recognize patterns, understand speech, and complete complex tasks. The AI tool employs algorithms to scan through lung ultrasound images for spotting features known as B-lines. These features are visible as bright, vertical abnormalities and are indicators of inflammation in patients with pulmonary complications. By learning from a combination of real and simulated data, it detects abnormalities in ultrasound scans that indicate a person has contracted COVID-19.

The findings of the research significantly enhance AI's role in medical diagnostics, helping healthcare professionals to promptly diagnose COVID-19 and other lung diseases. In addition to providing clinicians with the tool to rapidly assess the overwhelming number of patients in emergency rooms during a pandemic, the tool also paves the way for the development of wearables to monitor illnesses such as congestive heart failure, which can result in fluid overload in patients’ lungs, similar to COVID-19.

“We developed this automated detection tool to help doctors in emergency settings with high caseloads of patients who need to be diagnosed quickly and accurately, such as in the earlier stages of the pandemic,” said Muyinatu Bell, the John C. Malone Associate Professor of Electrical and Computer Engineering, Biomedical Engineering, and Computer Science at Johns Hopkins University. “Potentially, we want to have wireless devices that patients can use at home to monitor progression of COVID-19, too.”

“Early in the pandemic, we didn’t have enough ultrasound images of COVID-19 patients to develop and test our algorithms, and as a result our deep neural networks never reached peak performance,” said Lingyi Zhao, who developed the software while a postdoctoral fellow in Bell’s lab. “Now, we are proving that with computer-generated datasets we still can achieve a high degree of accuracy in evaluating and detecting these COVID-19 features.”

Related Links:
Johns Hopkins

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
Thyroid Shield
Standard Thyroid Shield
Portable X-Ray Unit
AJEX240H

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.